RE:RE:RE:A few thoughts jfm1330 wrote: If I understood well, Tanguay said that, as of now, only 48% of potential patients are covered by reimbursments, but that 100% will be reached six monts after approval, so around the beginning of September. So half of the patients are not even in the equation right now. When 100% of them will be and doctors get more at ease with the drug, growth should be strong.
Yep payor policies in 48% of covered patients is how he said it, while also saying 89% of scripts written so far have been approved. Would suggest they've targeted those areas were coverage is greatest and a portion of the markets waits to be openned in the coming months.